Clinical Trial Update: Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a radiolabeled monoclonal antibody with combination chemotherapy before stem cell transplant in high-risk lymphoid malignanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Hodgkin Lymphoma
• Mantle Cell Lymphoma
• T-cell Non-hodgkin Lymphoma

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-09-04